相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Insights from nanotechnology in COVID-19 treatment
Zhongmin Tang et al.
NANO TODAY (2021)
Emergence of a Novel Coronavirus Disease (COVID-19) and the Importance of Diagnostic Testing: Why Partnership between Clinical Laboratories, Public Health Agencies, and Industry Is Essential to Control the Outbreak
Matthew J. Binnicker
CLINICAL CHEMISTRY (2020)
Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan, China
Weier Wang et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Receptor recognition by novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS
Yushun Wan et al.
JOURNAL OF VIROLOGY (2020)
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
Roujian Lu et al.
LANCET (2020)
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
Nanshan Chen et al.
LANCET (2020)
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang et al.
LANCET (2020)
A novel coronavirus outbreak of global health concern
Chen Wang et al.
LANCET (2020)
Convalescent plasma as a potential therapy for COVID-19
Long Chen et al.
LANCET INFECTIOUS DISEASES (2020)
Asymptomatic cases in a family cluster with SARS-CoV-2 infection
Xingfei Pan et al.
LANCET INFECTIOUS DISEASES (2020)
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Peng Zhou et al.
NATURE (2020)
Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia
Qun Li et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Emerging 2019 Novel Coronavirus (2019-nCoV) Pneumonia
Fengxiang Song et al.
RADIOLOGY (2020)
CT Imaging of the 2019 Novel Coronavirus (2019-nCoV) Pneumonia
Junqiang Lei et al.
RADIOLOGY (2020)
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
Daniel Wrapp et al.
SCIENCE (2020)
The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2
Alexander E. Gorbalenya et al.
NATURE MICROBIOLOGY (2020)
Discovery of Bat Coronaviruses through Surveillance and Probe Capture-Based Next-Generation Sequencing
Bei Li et al.
MSPHERE (2020)
Nafamostat Mesylate Blocks Activation of SARS-CoV-2: New Treatment Option for COVID-19
Markus Hoffmann et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Progress and Concept for COVID-19 Vaccine Development
Suh-Chin Wu
BIOTECHNOLOGY JOURNAL (2020)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
Type I and Type III Interferons - Induction, Signaling, Evasion, and Application to Combat COVID-19
Annsea Park et al.
CELL HOST & MICROBE (2020)
Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study
Li-Li Ren et al.
CHINESE MEDICAL JOURNAL (2020)
Limits of Detection of 6 Approved RT-PCR Kits for the Novel SARS-Coronavirus-2 (SARS-CoV-2)
Xueliang Wang et al.
CLINICAL CHEMISTRY (2020)
COVID-19: Pathogenesis, cytokine storm and therapeutic potential of interferons
Shivraj Hariram Nile et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2020)
Subunit Vaccines Against Emerging Pathogenic Human Coronaviruses
Ning Wang et al.
FRONTIERS IN MICROBIOLOGY (2020)
Serological assays for severe acute respiratory syndrome coronavirus 2 (BARS-CoV-2), March 2020
Ranawaka A. P. M. Perera et al.
EUROSURVEILLANCE (2020)
Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan
Jasper Fuk-Woo Chan et al.
EMERGING MICROBES & INFECTIONS (2020)
Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event
D. Paraskevis et al.
INFECTION GENETICS AND EVOLUTION (2020)
Cytokine storm and immunomodulatory therapy in COVID-19: Role of chloroquine and anti-IL-6 monoclonal antibodies
Ming Zhao
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis
Jing Yang et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)
Favipiravir, an antiviral for COVID-19?
Eric A. Coomes et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2020)
Deployment of convalescent plasma for the prevention and treatment of COVID-19
Evan M. Bloch et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Convalescent plasma for patients with COVID-19
Furong Zeng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Positive rectal swabs in young patients recovered from coronavirus disease 2019 (COVID-19)
Bin Zhang et al.
JOURNAL OF INFECTION (2020)
Tocilizumab treatment in COVID-19: A single center experience
Pan Luo et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Performance of VivaDiag COVID-19 IgM/IgG Rapid Test is inadequate for diagnosis of COVID-19 in acute patients referring to emergency room department
Irene Cassaniti et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Chloroquine and hydroxychloroquine in the management of COVID-19: Much kerfuffle but little evidence
M. Roustit et al.
THERAPIE (2020)
Oligonucleotides and the COVID-19 Pandemic: A Perspective
John J. Rossi et al.
NUCLEIC ACID THERAPEUTICS (2020)
Covid-19: What do we know so far about a vaccine?
Elisabeth Mahase
BMJ-BRITISH MEDICAL JOURNAL (2020)
Interferon beta-1b for COVID-19
Sarah Shalhoub
LANCET (2020)
COVID-19: consider cytokine storm syndromes and immunosuppression
Puja Mehta et al.
LANCET (2020)
Research and Development on Therapeutic Agents and Vaccines for COVID-19 and Related Human Coronavirus Diseases
Cynthia Liu et al.
ACS CENTRAL SCIENCE (2020)
Coronavirus vaccines: key questions
Ewen Callaway
NATURE (2020)
The proximal origin of SARS-CoV-2
Kristian G. Andersen et al.
NATURE MEDICINE (2020)
Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study
Qingxian Cai et al.
ENGINEERING (2020)
Remdesivir for the Treatment of Covid-19-Final Report
John H. Beigel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19
B. Cao et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis
Ren Mao et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)
Molecular immune pathogenesis and diagnosis of COVID-19
Xiaowei Li et al.
JOURNAL OF PHARMACEUTICAL ANALYSIS (2020)
Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation: an open-label cohort study
Emanuel Della-Torre et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
The pivotal role of TMPRSS2 in coronavirus disease 2019 and prostate cancer
Veronica Mollica et al.
FUTURE ONCOLOGY (2020)
Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding
Tyler N. Starr et al.
CELL (2020)
Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus
Bette Korber et al.
CELL (2020)
Estimation of exponential growth rate and basic reproduction number of the coronavirus disease 2019 (COVID-19) in Africa
Salihu S. Musa et al.
INFECTIOUS DISEASES OF POVERTY (2020)
COVID-19 in people with diabetes: understanding the reasons for worse outcomes
Matteo Apicella et al.
LANCET DIABETES & ENDOCRINOLOGY (2020)
Clinical efficacy of antivirals against novel coronavirus (COVID-19): A review
Shahamah Jomah et al.
JOURNAL OF INFECTION AND PUBLIC HEALTH (2020)
Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19) A Review
W. Joost Wiersinga et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Monoclonal Antibodies for Prevention and Treatment of COVID-19
Mary Marovich et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Convalescent Plasma and COVID-19
Anurag N. Malani et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
RNA-Dependent RNA Polymerase as a Target for COVID-19 Drug Discovery
Wei Zhu et al.
SLAS DISCOVERY (2020)
Emerging coronaviruses: Genome structure, replication, and pathogenesis (vol 92, pg 418, 2020)
Yu Chen et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Dexamethasone nanomedicines for COVID-19
Twan Lammers et al.
NATURE NANOTECHNOLOGY (2020)
An mRNA Vaccine against SARS-CoV-2-Preliminary Report
L. A. Jackson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Emerging manufacturers engagements in the COVID-19 vaccine research, development and supply
Sonia Pagliusi et al.
VACCINE (2020)
Emergence of genomic diversity and recurrent mutations in SARS-CoV-2
Lucy van Dorp et al.
INFECTION GENETICS AND EVOLUTION (2020)
No small matter: a perspective on nanotechnology-enabled solutions to fight COVID-19
Georgia Wilson Jones et al.
NANOMEDICINE (2020)
Evolution of the COVID-19 vaccine development landscape
Tung Thanh Le et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Molecular docking study of potential phytochemicals and their effects on the complex of SARS-CoV2 spike protein and human ACE2
Anamika Basu et al.
SCIENTIFIC REPORTS (2020)
Covid-19: Hong Kong scientists report first confirmed case of reinfection
Jane Parry
BMJ-BRITISH MEDICAL JOURNAL (2020)
Covid-19: Pre-purchasing vaccine-sensible or selfish?
Ingrid Torjesen
BMJ-BRITISH MEDICAL JOURNAL (2020)
Coronavirus disease 2019 and gender-related mortality in European countries: A meta-analysis
Faustino R. Perez-Lopez et al.
MATURITAS (2020)
Possible Bat Origin of Severe Acute Respiratory Syndrome Coronavirus 2
Susanna K. P. Lau et al.
EMERGING INFECTIOUS DISEASES (2020)
A one-step, one-tube real-time RT-PCR based assay with an automated analysis for detection of SARS-CoV-2
Bhasker Dharavath et al.
HELIYON (2020)
Tocilizumab in patients with severe COVID-19: a retrospective cohort study
Giovanni Guaraldi et al.
LANCET RHEUMATOLOGY (2020)
Clinical course and outcome of 107 patients infected with the novel coronavirus, SARS-CoV-2, discharged from two hospitals in Wuhan, China
Dawei Wang et al.
CRITICAL CARE (2020)
Vital Surveillances: The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) - China, 2020
Zijian Feng et al.
CHINA CDC WEEKLY (2020)
Traditional Chinese Medicine in the Treatment of Patients Infected with 2019-New Coronavirus (SARS-CoV-2): A Review and Perspective
Yang Yang et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2020)
Epidemiological characteristics of COVID-19: a systematic review and meta-analysis
Malahat Khalili et al.
EPIDEMIOLOGY AND INFECTION (2020)
A Rapid and Specific Assay for the Detection of MERS-CoV
Pei Huang et al.
FRONTIERS IN MICROBIOLOGY (2018)
Liquorice (Glycyrrhiza glabra ): A phytochemical and pharmacological review
Giulia Pastorino et al.
PHYTOTHERAPY RESEARCH (2018)
Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology
Rudragouda Channappanavar et al.
SEMINARS IN IMMUNOPATHOLOGY (2017)
Chloroquine, an Endocytosis Blocking Agent, Inhibits Zika Virus Infection in Different Cell Models
Rodrigo Delvecchio et al.
VIRUSES-BASEL (2016)
Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes
Norbert Pardi et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Chloroquine inhibited Ebola virus replication in vitro but failed to protect against infection and disease in the in vivo guinea pig model
Stuart D. Dowall et al.
JOURNAL OF GENERAL VIROLOGY (2015)
The Nucleocapsid Protein of Coronaviruses Acts as a Viral Suppressor of RNA Silencing in Mammalian Cells
Lei Cui et al.
JOURNAL OF VIROLOGY (2015)
BCG vaccination in patients with severe combined immunodeficiency: Complications, risks, and vaccination policies
Beatriz E. Marciano et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2014)
Chloroquine interferes with dengue-2 virus replication in U937 cells
Kleber Juvenal Silva Farias et al.
MICROBIOLOGY AND IMMUNOLOGY (2014)
Anti-malaria drug chloroquine is highly effective in treating avian influenza A H5N1 virus infection in an animal model
Yiwu Yan et al.
CELL RESEARCH (2013)
Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4
Nianshuang Wang et al.
CELL RESEARCH (2013)
Cleavage and Activation of the Severe Acute Respiratory Syndrome Coronavirus Spike Protein by Human Airway Trypsin-Like Protease
Stephanie Bertram et al.
JOURNAL OF VIROLOGY (2011)
Inhibition of hepatitis C virus replication by chloroquine targeting virus-associated autophagy
Tomokazu Mizui et al.
JOURNAL OF GASTROENTEROLOGY (2010)
Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites
Sandrine Belouzard et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Lipid rafts are involved in SARS-CoV entry into Vero E6 cells
Yanning Lu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
A severe acute respiratory syndrome coronavirus that lacks the E gene is attenuated in vitro and in vivo
Marta L. DeDiego et al.
JOURNAL OF VIROLOGY (2007)
A contemporary view of coronavirus transcription
Stanley G. Sawicki et al.
JOURNAL OF VIROLOGY (2007)
Architecture of the SARS coronavirus prefusion spike
Daniel R. Beniac et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2006)
Ultrastructure and origin of membrane vesicles associated with the severe acute respiratory syndrome coronavirus replication complex
Eric J. Snijder et al.
JOURNAL OF VIROLOGY (2006)
New insights into the antiviral effects of chloroquine
A Savarino et al.
LANCET INFECTIOUS DISEASES (2006)
Identification of novel subgenomic RNAs and noncanonical transcription initiation signals of severe acute respiratory syndrome coronavirus
S Hussain et al.
JOURNAL OF VIROLOGY (2005)
Chloroquine is a potent inhibitor of SARS coronavirus infection and spread
Martin J. Vincent et al.
VIROLOGY JOURNAL (2005)
Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage
EJ Snijder et al.
JOURNAL OF MOLECULAR BIOLOGY (2003)
Efficacy of stronger neo-minophagen C compared between two doses administered three times a week on patients with chronic viral hepatitis
K Miyake et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2002)
Effect of glycyrrhizin, an active component of licorice roots, on HIV replication in cultures of peripheral blood mononuclear cells from HIV-seropositive patients
H Sasaki et al.
PATHOBIOLOGY (2002)
分享论文
